OverviewSuggest Edit

Asensus Surgical (also known as TransEnterix) is a medical device company developing minimally invasive devices for laparoscopic surgery. It is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The Company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Company also developed the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform.
HQDurham, NC, US

Latest Updates

Employees (est.) (Dec 2020)138(-13%)
Revenue (FY, 2020)$3.2 M(-62%)
Share Price (Apr 2021)$2.1(-21%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Asensus Surgical

Anthony Fernando

Anthony Fernando

President & Chief Executive Officer, Director
Eric Smith

Eric Smith

Chief Commercial Officer
Wesley Long

Wesley Long

Vice President of Customer Excellence
Amanda Owens

Amanda Owens

Global Head of People
Cameron Pedersen

Cameron Pedersen

Vice President of Global Research & Development
Shameze Rampertab

Shameze Rampertab

Executive Vice President and Chief Financial Officer
Show more

Asensus Surgical Office Locations

Asensus Surgical has offices in Durham, Milano, Chiyoda City, Bertrange and in 1 other location
Durham, NC, US (HQ)
1 TW Alexander Dr #160
Milano, IT
Viale dell’Innovazione 3
Bertrange, LU
33 Rue du puits Romain
Lugano, CH
Via Serafino Balestra 12
Show all (5)

Asensus Surgical Financials and Metrics

Asensus Surgical Revenue

Embed Graph
View revenue for all periods
Asensus Surgical's revenue was reported to be $3.18 m in FY, 2020 which is a 62.8% decrease from the previous period.

Revenue (Q1, 2021)


Gross profit (Q1, 2021)


Gross profit margin (Q1, 2021), %


Net income (Q1, 2021)


EBIT (Q1, 2021)


Market capitalization (12-Apr-2021)


Closing stock price (12-Apr-2021)


Cash (31-Mar-2021)



Asensus Surgical's current market capitalization is $916.9 m.
USDFY, 2018FY, 2019FY, 2020



Revenue growth, %


Cost of goods sold


Gross profit

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021



Cost of goods sold


Gross profit


Gross profit Margin, %

USDFY, 2018FY, 2019FY, 2020



Accounts Receivable




Current Assets

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021



Accounts Receivable




Current Assets

USDFY, 2018FY, 2019FY, 2020

Net Income


Depreciation and Amortization




Accounts Payable

USDQ2, 2014Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income


Depreciation and Amortization




Accounts Payable

Show all financial metrics

Asensus Surgical Operating Metrics

FY, 2018FY, 2019FY, 2020

Patent Applications


Patents (Foreign)


Patents (US)

Show all operating metrics

Asensus Surgical Acquisitions / Subsidiaries

Company NameDateDeal Size
MST Medical Surgery TechnologiesSeptember 23, 2018
SOFARSeptember 22, 2015$99.8 m
Asensus International, Inc.
Asensus Surgical Canada, Inc.
Asensus Surgical Europe, Sarl
Asensus Surgical Israel LTD
Asensus Surgical Italia, S.r.l.
Asensus Surgical Netherlands B.V.
Asensus Surgical US, Inc.
SafeStitch, LLC
Show more

Asensus Surgical Revenue Breakdown

Embed Graph

Asensus Surgical revenue breakdown by business segment: 49.2% from Services, 26.5% from Instruments and accessories and 24.3% from Systems

Asensus Surgical Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Asensus Surgical Online and Social Media Presence

Embed Graph

Asensus Surgical News and Updates

Robot-Assisted Surgical Systems Market To See Massive Growth By 2027| Auris Surgical Robotics, Transenterix, Microbot Medical, Intuitive Surgical, Medrobotics

Robot-Assisted Surgical are surgical procedures performed using robotic systems. These were developed to overthrow the preexisting limitations of minimally invasive surgical procedures and to reinforce the capabilities of surgeons performing open surgery. Posted via Industry Today. Follow us on Twit…

Surgical Robot Market Future Outlook Accuray, Stryker Corporation, TransEnterix, Intuitive, and Hocoma

WiseGuyRerports.com Presents “Surgical Robot Market, By Product (Robot Systems, Instrument & Accessories and Services), By Brands, By Application and Geography” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Surgical Robots Market Report 2020 Top Companies- Intuitive Surgical, Stryker, Medtech, TransEnterix, THINK Surgical and more...

A new market study, titled “Global Surgical Robots Market Growth 2020-2025”, has been featured on WiseGuyReports. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Medical Devices Pipeline Assessment for Endoscopic Instruments 2020, Featuring Agile EndoSurgery Inc, AridoEndo and TransEnterix Inc

DUBLIN, May 21, 2020 /PRNewswire/ -- The "Endoscopic Instruments - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of Endoscopic Instruments currently in pipeline stage. The report provides...

TransEnterix hopes to raise $20.3M in public offering for surgical robotics

TransEnterix is publicly offering stock after regulatory approvals of its Senhance robotic surgical system and disappointing financial results. The post TransEnterix hopes to raise $20.3M in public offering for surgical robotics appeared first on Design World.

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TransEnterix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, March 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of TransEnterix, Inc. (NYSE American: TRXC). If...
Show more

Asensus Surgical Blogs

Osteopore and Singular Health collaborate on AI-powered cranial implant design process

Bone healing biotech Osteopore (ASX: OSX) has inked a deal with Singular Health Group (ASX: SHG) for a comparative study between Osteopore’s existing cranial implant design process and a new artificial intelligence design engine in a clinical environment. The study seeks to validate the results of t…

Hearing aid innovations recognised in CES 2022 awards

Hearing aid innovator Signia has seen two of its innovations selected as honourees in the Consumer Electronics Show 2022 Innovation Awards. The CES Innovation Awards program is an annual competition honouring outstanding design and engineering in 27 consumer technology product categories. Signia’s G…

Start-up receives investment for device to measure brainwaves

Yokogawa Electric Corporation has invested in CyberneX, a Japan-based start-up that has developed a compact and lightweight earphone-type device capable of measuring brainwaves in real time. CyberneX and Yokogawa will collaborate in the conduct of empirical research with the aim of constructing a pl…

New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrasonography

Masimo announced the findings of an abstract presented at ANESTHESIOLOGY 2021 in San Diego, in which Drs. Anita Kulkarni and Arti Dalal at the Rajiv Gandhi Cancer Institute in New Delhi, India evaluated the use of noninvasive, continuous Masimo PVi® as part of goal-directed fluid therapy (GDFT) to g…

Altair Medical announces rebrand to PneumoWave

UK based Altair Medical has announced, as part of its ongoing growth story, that it is rebranding to PneumoWave. The name reflects the digital therapeutics platform that the company believes will transform respiratory healthcare. In a step towards commercial launch of the platform, a multi-centre pr…

Study shows safety and efficacy of robotic-guided ablation to treat paediatric arrhythmias

Stereotaxis has announced publication of a study in the International Journal of Cardiology: Heart & Vascular demonstrating superior safety and efficacy of Stereotaxis’ robotic technology to treat atrioventricular reentry tachycardia (AVRT) and atrioventricular nodal reentry tachycardia (AVNRT) …
Show more

Asensus Surgical Frequently Asked Questions

  • When was Asensus Surgical founded?

    Asensus Surgical was founded in 2006.

  • Who are Asensus Surgical key executives?

    Asensus Surgical's key executives are Anthony Fernando, Eric Smith and Wesley Long.

  • How many employees does Asensus Surgical have?

    Asensus Surgical has 138 employees.

  • What is Asensus Surgical revenue?

    Latest Asensus Surgical annual revenue is $3.2 m.

  • What is Asensus Surgical revenue per employee?

    Latest Asensus Surgical revenue per employee is $23 k.

  • Who are Asensus Surgical competitors?

    Competitors of Asensus Surgical include Distalmotion, THINK Surgical and AcuSurgical.

  • Where is Asensus Surgical headquarters?

    Asensus Surgical headquarters is located at 1 TW Alexander Dr #160, Durham.

  • Where are Asensus Surgical offices?

    Asensus Surgical has offices in Durham, Milano, Chiyoda City, Bertrange and in 1 other location.

  • How many offices does Asensus Surgical have?

    Asensus Surgical has 5 offices.